Xponance’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Buy
1,984
+786
+66% +$278K ﹤0.01% 878
2026
Q1
$385K Buy
1,198
+395
+49% +$118K ﹤0.01% 1138
2025
Q4
$208K Buy
+803
New +$183K ﹤0.01% 1373
2025
Q1
Sell
-1,105
Closed -$249K 1469
2024
Q4
$249K Buy
1,105
+86
+8% +$19.2K ﹤0.01% 1197
2024
Q3
$212K Buy
+1,019
New +$205K ﹤0.01% 1230
2023
Q2
Sell
-1,575
Closed -$307K 1275
2023
Q1
$307K Sell
1,575
-59
-4% -$11K ﹤0.01% 1038
2022
Q4
$300K Buy
+1,634
New +$256K ﹤0.01% 1036

Other funds holding MSGS

Xponance's MSGS Position: Q2 2026 in Review

Xponance increased its Madison Square Garden (MSGS) stake by 66% in Q2 2026, buying an estimated $278K and bringing the position to 1,984 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Xponance first reported a position in MSGS in Q4 2022 and has held it in 7 quarters since. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Xponance held 1,984 shares of Madison Square Garden worth $797K as of Q2 2026.
  • Xponance bought 786 Madison Square Garden shares in Q2 2026, an estimated $278K.
  • Madison Square Garden made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #878 holding.
  • Xponance first reported a position in Madison Square Garden in Q4 2022 and has held it in 7 quarters since.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.